Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ANAPTYSBIO, INC (ANAB)

  • Business News
  • April 20, 2026, 13:15 UTC
  • 5
  • 1 comments

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Market reaction Comment Full text

LA-Z-BOY INC (LZB)

  • Business News
  • April 20, 2026, 13:15 UTC
  • 3
  • 1 comments

La-Z-Boy Incorporated Introduces AudioLuxe, a New Premium Audio Furniture Line with Sound by Klipsch

Market reaction Comment Full text

BLENDER FINANCIAL TECHLOGIES LTD (BLND)

  • Business News
  • April 20, 2026, 13:11 UTC
  • 5
  • 1 comments

Form 8.3

Market reaction Comment Full text

BLENDER FINANCIAL TECHLOGIES LTD (BLND)

  • Business News
  • April 20, 2026, 13:10 UTC
  • 5
  • 1 comments

Form 8.3 - Amendment

Market reaction Comment Full text

GBANK FINANCIAL HOLDINGS INC. (GBFH)

  • Business News
  • April 20, 2026, 13:09 UTC
  • 5
  • 1 comments

GBank Financial Holdings Inc. Announces First Quarter 2026 Quarterly Earnings Call Scheduled for Wednesday, April 29th, at 2:00 P.M., Pacific Time

Market reaction Comment Full text

ODDITY TECH LTD (ODD)

  • Business News
  • April 20, 2026, 13:06 UTC
  • 5
  • 1 comments

NASDAQ: ODD CLASS ACTION NOTICE: Berger Montague Encourages ODDITY Tech Ltd. (NASDAQ: ODD) Investors to Inquire About a Securities Fraud Class Action

Market reaction Comment Full text

LUMEN TECHNOLOGIES, INC. (LUMN)

  • Business News
  • April 20, 2026, 13:05 UTC
  • 5
  • 1 comments

Lumen Technologies, Inc. and Qwest Corporation Announce Commencement of Exchange Offers and Consent Solicitations and Intention to Delist Notes

Market reaction Comment Full text

ADS-TEC ENERGY PUBLIC LTD CO (ADSE)

  • Business News
  • April 20, 2026, 13:01 UTC
  • 5
  • 1 comments

ADS-TEC Energy at Hannover Messe 2026: Battery-based infrastructure as a response to volatile energy markets

Market reaction Comment Full text

Oragenics Inc. (OGEN)

  • Business News
  • April 20, 2026, 13:00 UTC
  • 5
  • 1 comments

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Market reaction Comment Full text

Abcellera Biologics Inc (ABCL)

  • Business News
  • April 20, 2026, 13:00 UTC
  • 5
  • 1 comments

Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Market reaction Comment Full text
  • Previous
  • 1118
  • 1119
  • 1120
  • 1121
  • 1122
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158461)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin